FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients

被引：0
|
作者：
Riedl, Christopher
Pinker, Katja
Ong, Leonard
Jochelson, Maxine S.
Ulaner, Gary
McArthur, Heather L.
Dickler, Maura N.
Weber, Wolfgang
机构：
[1] Mem Sloan Kettering Canc Ctr, Mol Imaging & Therapy Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.1051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1051
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Incidence of Pulmonary Embolism and Associated FDG-PET Findings in IV Contrast-Enhanced PET/CT
    Flavell, Robert R.
    Behr, Spencer C.
    Brunsing, Ryan L.
    Naeger, David M.
    Pampaloni, Miguel Hernandez
    ACADEMIC RADIOLOGY, 2014, 21 (06) : 718 - 725
  • [22] Early interim negative FDG-PET/CT is a high predictive factor for progression-free survival in Hodgkin lymphoma.
    Dann, Eldad J.
    Bar-Shalom, Rachel
    Tamir, Ada
    Haim, Nissim
    Avivi, Irit
    Gaitini, Diana
    Ben-Shachar, Menachem
    Israel, Ora
    Rowe, Jacob M.
    Epelbaum, Ron
    BLOOD, 2006, 108 (11) : 227B - 227B
  • [23] Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT
    Kazuhiro Kitajima
    Koji Murakami
    Erena Yamasaki
    Yasushi Domeki
    Yasushi Kaji
    Satoru Morita
    Narufumi Suganuma
    Kazuro Sugimura
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36
  • [24] Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: Comparison with PET and enhanced CT
    Dirisamer, Albert
    Halpern, Benjamin S.
    Floery, Daniel
    Wolf, Florian
    Beheshti, Mohsen
    Mayerhoefer, Marius E.
    Langsteger, Werner
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 73 (02) : 324 - 328
  • [25] Comparison of FDG-PET/CT and contrast enhanced CT (ceCT) in detection of locoregional recurrence in thyroid cancer (TC) patients
    Jiang, Manli
    Khan, Shahid
    Genden, Eric
    Heiba, Sherif
    Machac, Josef
    Kostakoglu, Lale
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [26] Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT
    Kitajima, Kazuhiro
    Murakami, Koji
    Yamasaki, Erena
    Domeki, Yasushi
    Kaji, Yasushi
    Morita, Satoru
    Suganuma, Narufumi
    Sugimura, Kazuro
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (03) : 362 - 372
  • [27] Reproducibility of Response Assessment in Metastatic Breast Cancer Patients with Contrast-enhanced CT and FDG PET/CT
    Lebron, L.
    Riedl, C.
    Long, N.
    Pinker-Domenig, K.
    Weber, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S76 - S76
  • [28] Is FDG-PET/CT useful in initial evaluation of patients with clinical stage II breast cancer?
    Groheux, David
    Espie, Marc
    Vercellino, Laetitia
    Hamy, Anne-Sophie
    Giacchetti, Sylvie
    Berenger, Nathalie
    Misset, Jean-Louis
    Hindie, Elif
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [29] Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer
    Kim J.
    Lim S.T.
    Na C.J.
    Han Y.-H.
    Kim C.-Y.
    Jeong H.-J.
    Sohn M.-H.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (1) : 33 - 40
  • [30] 18F-FDG PET/CT radiomics signature and clinical parameters predict progression-free survival in breast cancer patients: A preliminary study
    Xu, Xiaojun
    Sun, Xun
    Ma, Ling
    Zhang, Huangqi
    Ji, Wenbin
    Xia, Xiaotian
    Lan, Xiaoli
    FRONTIERS IN ONCOLOGY, 2023, 13
12345